{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699993642623488.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1155/2017/4909452"}},{"identifier":{"@type":"URI","@value":"http://downloads.hindawi.com/journals/bmri/2017/4909452.pdf"}},{"identifier":{"@type":"URI","@value":"http://downloads.hindawi.com/journals/bmri/2017/4909452.xml"}}],"dc:title":[{"@value":"Etiological and Resistance Profile of Bacteria Involved in Urinary Tract Infections in Young Children"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p><jats:italic>Background.</jats:italic>The objective of this study was to identify the bacteria most frequently responsible for urinary tract infection (UTI) in the population of under-2-year-olds in our geographic area and to evaluate the activity of antibiotics widely used for UTI treatment during a 4-year study period.<jats:italic>Materials and Methods.</jats:italic>A retrospective analysis was conducted of data on the identification and susceptibility of microorganisms isolated in urine samples from children under 2 years of age.<jats:italic>Results.</jats:italic>A total of 1,045 uropathogens were isolated.<jats:italic>Escherichia coli</jats:italic>accounted for the majority (60.3%) of these, followed by<jats:italic>Enterococcus faecalis</jats:italic>(22.4%) and<jats:italic>Klebsiella</jats:italic>spp. (6.5%). The highest<jats:italic>E. coli</jats:italic>susceptibility rates (>90%) were to piperacillin-tazobactam, cefuroxime, cefotaxime, ceftazidime, imipenem, gentamicin, nitrofurantoin, and fosfomycin, and the lowest were to amoxicillin-clavulanic acid and cotrimoxazole. Among all bacteria isolated, we highlight the overall high activity of piperacillin-tazobactam, imipenem, nitrofurantoin, and fosfomycin against both community and hospital isolates and the reduced activity of amoxicillin-clavulanic acid, cephalosporins, gentamicin, and cotrimoxazole. There was no significant change in the total activity of any of the studied antibiotics over the 4-year study period.<jats:italic>Conclusion.</jats:italic>Empiric treatment with amoxicillin-clavulanic acid, cotrimoxazole, cephalosporins, and gentamicin may be inadequate due to their limited activity against uropathogens in our setting.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699993642623488","@type":"Researcher","foaf:name":[{"@value":"Antonio Sorlózano-Puerto"}],"jpcoar:affiliationName":[{"@value":"Departamento de Microbiología, Universidad de Granada-ibs.Granada, Granada, Spain"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993642623491","@type":"Researcher","foaf:name":[{"@value":"José María Gómez-Luque"}],"jpcoar:affiliationName":[{"@value":"UGC de Pediatría, Complejo Hospitalario Universitario de Granada-ibs.Granada, Hospital General Virgen de las Nieves, Granada, Spain"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993642623489","@type":"Researcher","foaf:name":[{"@value":"Juan de Dios Luna-del-Castillo"}],"jpcoar:affiliationName":[{"@value":"Departamento de Bioestadística, Universidad de Granada-ibs.Granada, Granada, Spain"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993642623490","@type":"Researcher","foaf:name":[{"@value":"José María Navarro-Marí"}],"jpcoar:affiliationName":[{"@value":"Laboratorio de Microbiología, Complejo Hospitalario Universitario de Granada-ibs.Granada, Hospital General Virgen de las Nieves, Granada, Spain"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699993642623492","@type":"Researcher","foaf:name":[{"@value":"José Gutiérrez-Fernández"}],"jpcoar:affiliationName":[{"@value":"Departamento de Microbiología, Universidad de Granada-ibs.Granada, Granada, Spain"},{"@value":"Laboratorio de Microbiología, Complejo Hospitalario Universitario de Granada-ibs.Granada, Hospital General Virgen de las Nieves, Granada, Spain"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"23146133"},{"@type":"EISSN","@value":"23146141"}],"prism:publicationName":[{"@value":"BioMed Research International"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2017","prism:volume":"2017","prism:startingPage":"1","prism:endingPage":"8"},"reviewed":"false","dc:rights":["http://creativecommons.org/licenses/by/4.0/"],"url":[{"@id":"http://downloads.hindawi.com/journals/bmri/2017/4909452.pdf"},{"@id":"http://downloads.hindawi.com/journals/bmri/2017/4909452.xml"}],"createdAt":"2017-04-11","modifiedAt":"2025-06-17","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050287297275630592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur, Nepal"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1155/2017/4909452"},{"@type":"CROSSREF","@value":"10.1186/s41182-020-00251-6_references_DOI_F5F0aHqi7ta8iUy2DbiCvKBYgUL"}]}